International Immunology, Vol 10, 1847-1851, Copyright © 1998 by Oxford University Press
C Legendre, M Raphael, G Gras, EA Lefevre, J Feuillard, D Dormont and Y Richard
A centrofollicular hyperplasia is present within secondary lymphoid organs
during all the asymptomatic phase of the HIV disease. Although this
hyperplasia has been well characterized by histological studies, the nature
of the phenotypic alterations in B cell populations occurring within HIV+
lymphoid organs remains to be established. By immunohistochemistry, we thus
investigated whether a particular germinal center (GC) B cell population
was increased during HIV-induced hyperplasia and whether any phenotypic
change was specific to HIV-1 infection. As compared to normal tonsils
(three cases) and HIV- hyperplastic lymph nodes (eight patients), we
observed a loss of GC polarization in all HIV+ sections (11 patients), with
no more delineation between dark and light zones, as shown by Ki67, CD10,
CD77, CD95 and CD86 staining. In contrast to CD86 expression which remained
as intensive in HIV+ as in HIV- lymph nodes, CD80 staining was strongly
decreased in GC of HIV+ lymph nodes but not in their extrafollicular zones.
The loss of CD80 expression from CD19+ B cells was also observed by
cytometric analysis of cell suspensions of three HIV+ patients. Although we
found no evidence of an increase in a particular GC B cell subset in
HIV-1-induced hyperplasia, the strong GC disorganization observed may
induce impaired cell-cell interactions and thus participate in the loss of
CD80 antigen. In contrast to HIV- situations where CD80 and CD86 was
similarly expressed on B cells, the lower level of CD80 expression in HIV+
GC may favor Th2 T cell responses through CD86-CD28 interactions.
ARTICLES
CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients
CEA, Service de Neurovirologie, DSV/DRM, CRSSA, IPSC, Fontenay aux Roses, France.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Badr, G. Borhis, D. Treton, C. Moog, O. Garraud, and Y. Richard HIV Type 1 Glycoprotein 120 Inhibits Human B Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 12, CC Chemokine Ligand (CCL)20, and CCL21 J. Immunol., July 1, 2005; 175(1): 302 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Borkow and Z. Bentwich Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy Clin. Microbiol. Rev., October 1, 2004; 17(4): 1012 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malaspina, S. Moir, S. Kottilil, C. W. Hallahan, L. A. Ehler, S. Liu, M. A. Planta, T.-W. Chun, and A. S. Fauci Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function J. Immunol., June 15, 2003; 170(12): 5965 - 5972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Margolin, E. F. Helmuth Saunders, B. Bronfin, N. de Rosa, M. K. Axthelm, X. Alvarez, and N. L. Letvin High Frequency of Virus-Specific B Lymphocytes in Germinal Centers of Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys J. Virol., March 19, 2002; 76(8): 3965 - 3973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang and D. E. Lewis CD86 expression correlates with amounts of HIV produced by macrophages in vitro J. Leukoc. Biol., March 1, 2001; 69(3): 405 - 413. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Tateyama, N. Oyaizu, T. W. McCloskey, S. Than, and S. Pahwa CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway Blood, July 1, 2000; 96(1): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Lefevre, R. Krzysiek, E. P. Loret, P. Galanaud, and Y. Richard Cutting Edge: HIV-1 Tat Protein Differentially Modulates the B Cell Response of Naive, Memory, and Germinal Center B Cells J. Immunol., August 1, 1999; 163(3): 1119 - 1122. [Abstract] [Full Text] [PDF]
|
|